Starlake Bioscience Co Inc Zhaoqing Guangdong (600866) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.147x

Based on the latest financial reports, Starlake Bioscience Co Inc Zhaoqing Guangdong (600866) has a cash flow conversion efficiency ratio of 0.147x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥1.25 Billion ≈ $183.09 Million USD) by net assets (CN¥8.50 Billion ≈ $1.24 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Starlake Bioscience Co Inc Zhaoqing Guan (600866) defensive interval to measure how many days the company can operate on defensive assets alone.

Starlake Bioscience Co Inc Zhaoqing Guangdong - Cash Flow Conversion Efficiency Trend (1998–2025)

This chart illustrates how Starlake Bioscience Co Inc Zhaoqing Guangdong's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Starlake Bioscience Co Inc Zhaoqing Guangdong Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Starlake Bioscience Co Inc Zhaoqing Guangdong ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
OVH GROUPE UNSP.ADR/1/2 F:7U70	N/A
Guangdong Lyric Robot Automation Co Ltd SHG:688499	0.165x
Bombay Burmah Trading Corporation Limited NSE:BBTC	0.039x
Preferred Bank NASDAQ:PFBC	0.059x
Faraday Copper Corp. TO:FDY	0.012x
Usinas Siderúrgicas de Minas Gerais S.A SA:USIM3	0.016x
Ho Chi Minh City Securities Corp VN:HCM	-0.525x
Zhejiang Grandwall Electric Science&Technology Co Ltd Class A SHG:603897	0.061x

Annual Cash Flow Conversion Efficiency for Starlake Bioscience Co Inc Zhaoqing Guangdong (1998–2025)

The table below shows the annual cash flow conversion efficiency of Starlake Bioscience Co Inc Zhaoqing Guangdong from 1998 to 2025. For the full company profile with market capitalisation and key ratios, see Starlake Bioscience Co Inc Zhaoqing Guan market cap and net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥8.45 Billion ≈ $1.24 Billion	CN¥1.29 Billion ≈ $189.06 Million	0.153x	-48.80%
2024-12-31	CN¥8.03 Billion ≈ $1.18 Billion	CN¥2.40 Billion ≈ $350.87 Million	0.299x	+12.86%
2023-12-31	CN¥7.66 Billion ≈ $1.12 Billion	CN¥2.03 Billion ≈ $296.48 Million	0.265x	+10.25%
2022-12-31	CN¥6.93 Billion ≈ $1.01 Billion	CN¥1.66 Billion ≈ $243.28 Million	0.240x	+121.16%
2021-12-31	CN¥1.78 Billion ≈ $259.83 Million	CN¥192.63 Million ≈ $28.19 Million	0.108x	-27.57%
2020-12-31	CN¥1.67 Billion ≈ $244.23 Million	CN¥249.99 Million ≈ $36.58 Million	0.150x	+6.82%
2019-12-31	CN¥1.52 Billion ≈ $222.47 Million	CN¥213.17 Million ≈ $31.19 Million	0.140x	+164.58%
2018-12-31	CN¥956.42 Million ≈ $139.95 Million	CN¥50.69 Million ≈ $7.42 Million	0.053x	+20.96%
2017-12-31	CN¥914.14 Million ≈ $133.77 Million	CN¥40.05 Million ≈ $5.86 Million	0.044x	+14.12%
2016-12-31	CN¥1.07 Billion ≈ $156.93 Million	CN¥41.17 Million ≈ $6.02 Million	0.038x	+1365.65%
2015-12-31	CN¥1.05 Billion ≈ $153.37 Million	CN¥2.75 Million ≈ $401.72K	0.003x	+119.01%
2014-12-31	CN¥1.47 Billion ≈ $214.84 Million	CN¥-20.22 Million ≈ $-2.96 Million	-0.014x	+28.32%
2013-12-31	CN¥1.47 Billion ≈ $214.44 Million	CN¥-28.16 Million ≈ $-4.12 Million	-0.019x	+88.62%
2012-12-31	CN¥1.63 Billion ≈ $239.18 Million	CN¥-276.02 Million ≈ $-40.39 Million	-0.169x	-561.92%
2011-12-31	CN¥1.80 Billion ≈ $263.72 Million	CN¥65.88 Million ≈ $9.64 Million	0.037x	-43.78%
2010-12-31	CN¥1.61 Billion ≈ $235.47 Million	CN¥104.63 Million ≈ $15.31 Million	0.065x	-79.05%
2009-12-31	CN¥1.02 Billion ≈ $149.30 Million	CN¥316.73 Million ≈ $46.35 Million	0.310x	+61.84%
2008-12-31	CN¥776.46 Million ≈ $113.62 Million	CN¥148.93 Million ≈ $21.79 Million	0.192x	+72.98%
2007-12-31	CN¥742.02 Million ≈ $108.58 Million	CN¥82.28 Million ≈ $12.04 Million	0.111x	+181.49%
2006-12-31	CN¥892.18 Million ≈ $130.55 Million	CN¥35.14 Million ≈ $5.14 Million	0.039x	-26.41%
2005-12-31	CN¥874.86 Million ≈ $128.02 Million	CN¥46.83 Million ≈ $6.85 Million	0.054x	+64.59%
2004-12-31	CN¥893.38 Million ≈ $130.73 Million	CN¥29.05 Million ≈ $4.25 Million	0.033x	-80.35%
2003-12-31	CN¥904.58 Million ≈ $132.37 Million	CN¥149.70 Million ≈ $21.91 Million	0.165x	-24.57%
2002-12-31	CN¥834.94 Million ≈ $122.18 Million	CN¥183.18 Million ≈ $26.81 Million	0.219x	+172.54%
2001-12-31	CN¥755.58 Million ≈ $110.57 Million	CN¥60.82 Million ≈ $8.90 Million	0.081x	-35.25%
2000-12-31	CN¥751.40 Million ≈ $109.95 Million	CN¥93.41 Million ≈ $13.67 Million	0.124x	+65.11%
1999-12-31	CN¥703.50 Million ≈ $102.94 Million	CN¥52.97 Million ≈ $7.75 Million	0.075x	-52.56%
1998-12-31	CN¥448.25 Million ≈ $65.59 Million	CN¥71.14 Million ≈ $10.41 Million	0.159x	--

About Starlake Bioscience Co Inc Zhaoqing Guangdong

SHG:600866 China Biotechnology

Market Cap

$1.16 Billion

CN¥7.93 Billion CNY

Market Cap Rank

#8425 Global

#2069 in China

Share Price

CN¥4.77

Change (1 day)

-1.04%

52-Week Range

CN¥4.64 - CN¥8.39

All Time High

CN¥9.46